Jaguar Health, Inc. (JAGX)

NASDAQ: JAGX · IEX Real-Time Price · USD
0.0729
+0.0039 (5.65%)
At close: Mar 27, 2024, 4:00 PM
0.0765
+0.0036 (4.94%)
Pre-market: Mar 28, 2024, 6:09 AM EDT

Jaguar Health Revenue

Jaguar Health had revenue of $10.72M in the twelve months ending September 30, 2023, down -0.51% year-over-year. Revenue in the quarter ending September 30, 2023 was $2.81M, a -10.70% decrease year-over-year. In the year 2022, Jaguar Health had annual revenue of $11.96M with 175.80% growth.

Revenue (ttm)
$10.72M
Revenue Growth
-0.51%
P/S Ratio
1.36
Revenue / Employee
$178,683
Employees
60
Market Cap
14.60M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202211.96M7.62M175.80%
Dec 31, 20214.34M-5.05M-53.81%
Dec 31, 20209.39M3.61M62.51%
Dec 31, 20195.78M1.36M30.77%
Dec 31, 20184.42M54.96K1.26%
Dec 31, 20174.36M4.22M2,981.61%
Dec 31, 2016141.52K-116.86K-45.23%
Dec 31, 2015258.38K--
Dec 31, 20140--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Acorda Therapeutics 111.12M
Star Equity Holdings 45.79M
T2 Biosystems 11.00M
Biomerica 5.50M
Immuron 2.43M
Talphera 651.00K
Revenue Rankings